| Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice P Sonveaux, F Végran, T Schroeder, MC Wergin, J Verrax, ZN Rabbani, ... The Journal of clinical investigation 118 (12), 3930-3942, 2008 | 1974 | 2008 |
| A genomic strategy to refine prognosis in early-stage non–small-cell lung cancer A Potti, S Mukherjee, R Petersen, HK Dressman, A Bild, J Koontz, ... New England Journal of Medicine 355 (6), 570-580, 2006 | 706 | 2006 |
| Genomic signatures to guide the use of chemotherapeutics A Potti, HK Dressman, A Bild, RF Riedel, G Chan, R Sayer, J Cragun, ... Nature medicine 12 (11), 1294-1300, 2006 | 695 | 2006 |
| Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non–small-cell lung cancer: Cancer and … EE Vokes, JE Herndon, MJ Kelley, MG Cicchetti, N Ramnath, H Neill, ... Journal of clinical oncology 25 (13), 1698-1704, 2007 | 606 | 2007 |
| Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action PW Finch, X He, MJ Kelley, A Üren, RP Schaudies, NC Popescu, ... Proceedings of the National Academy of Sciences 94 (13), 6770-6775, 1997 | 534 | 1997 |
| Screening for lung cancer: a review of the current literature PB Bach, MJ Kelley, RC Tate, DC McCrory Chest 123 (1), 72S-82S, 2003 | 425 | 2003 |
| A pathway-based classification of human breast cancer ML Gatza, JE Lucas, WT Barry, JW Kim, Q Wang, M D. Crawford, ... Proceedings of the National Academy of Sciences 107 (15), 6994-6999, 2010 | 400 | 2010 |
| Implementation of lung cancer screening in the Veterans Health Administration LS Kinsinger, C Anderson, J Kim, M Larson, SH Chan, HA King, KL Rice, ... JAMA internal medicine 177 (3), 399-406, 2017 | 383 | 2017 |
| T (brachyury) gene duplication confers major susceptibility to familial chordoma XR Yang, D Ng, DA Alcorta, NJ Liebsch, E Sheridan, S Li, AM Goldstein, ... Nature genetics 41 (11), 1176-1178, 2009 | 327 | 2009 |
| Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9 AK Lalwani, JA Goldstein, MJ Kelley, W Luxford, CM Castelein, ... The American Journal of Human Genetics 67 (5), 1121-1128, 2000 | 312 | 2000 |
| Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly MJ Kelley, W Jawien, TL Ortel, JF Korczak Nature genetics 26 (1), 106-108, 2000 | 295 | 2000 |
| Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer SJ Kim, ZN Rabbani, MW Dewhirst, Z Vujaskovic, RT Vollmer, ... Lung cancer 49 (3), 325-335, 2005 | 254 | 2005 |
| Screening for lung cancer: ACCP evidence-based clinical practice guidelines PB Bach, GA Silvestri, M Hanger, JR Jett Chest 132 (3), 69S-77S, 2007 | 253 | 2007 |
| Cancer incidence among patients of the US Veterans Affairs health care system LL Zullig, GL Jackson, RA Dorn, DT Provenzale, R McNeil, CM Thomas, ... Military medicine 177 (6), 693-701, 2012 | 224 | 2012 |
| Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A Y Zhang, MA Conti, D Malide, F Dong, A Wang, YA Shmist, C Liu, P Zerfas, ... Blood, The Journal of the American Society of Hematology 119 (1), 238-250, 2012 | 199 | 2012 |
| Immunization With Mutant p53- and K-ras–Derived Peptides in Cancer Patients: Immune Response and Clinical Outcome DP Carbone, IF Ciernik, MJ Kelley, MC Smith, S Nadaf, D Kavanaugh, ... Journal of Clinical Oncology 23 (22), 5099-5107, 2005 | 187 | 2005 |
| Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non–small-cell lung cancer: An analysis of Veterans Health Administration data R Santana-Davila, K Devisetty, A Szabo, R Sparapani, C Arce-Lara, ... Journal of clinical oncology 33 (6), 567-574, 2015 | 158 | 2015 |
| Cancer incidence among patients of the US Veterans Affairs Health Care System: 2010 update LL Zullig, KJ Sims, R McNeil, CD Williams, GL Jackson, D Provenzale, ... Military medicine 182 (7), e1883-e1891, 2017 | 157 | 2017 |
| Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer MJ Kelley, RI Linnoila, IL Avis, MS Georgiadis, F Cuttitta, JL Mulshine, ... Chest 112 (1), 256-261, 1997 | 126 | 1997 |
| Genotype–phenotype correlation in MYH9‐related thrombocytopenia F Dong, S Li, N Pujol‐Moix, NLC Luban, SW Shin, JH Seo, A Ruiz‐Saez, ... British journal of haematology 130 (4), 620-627, 2005 | 124 | 2005 |
Leah L. Zullig, PhD, MPHDuke University | Durham VA Center for Health Services Research in Primary Careبريد إلكتروني تم التحقق منه على duke.edu